{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:33:58Z","timestamp":1787009638078,"version":"build-2736575974"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Among specific autoantibodies in DM, the anti\u2013small ubiquitin-like modifier activating enzyme (SAE) antibody is rare. We aim to describe the clinical characteristics, cancer prevalence, and muscle pathology of anti-SAE\u2013positive DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with a diagnosis of DM and sera positive for the anti-SAE antibody were recruited from 19 centres in this retrospective observational study. The available muscular biopsies were reviewed. We conducted a comparison with anti-SAE\u2013negative DM and a review of the literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the patients in the study (n\u2009=\u200949), 84% were women. Skin involvement was typical in 96% of patients, with 10% having calcinosis, 18% ulceration and 12% necrosis; 35% presented with a widespread skin rash. Muscular disease affected 84% of patients, with mild weakness [Medical Research Council (MRC) scale 4 (3, 5)], although 39% of patients had dysphagia. Muscular biopsies showed typical DM lesions. Interstitial lung disease was found in 21% of patients, mainly with organizing pneumonia pattern, and 26% of patients showed dyspnoea. Cancer-associated myositis was diagnosed in 16% of patients and was responsible for the majority of deaths, its prevalence being five times that of the general population. IVIG therapy was administered to 51% of the patients during the course of the disease. Comparison with anti-SAE\u2013negative DM (n\u2009=\u200985) showed less and milder muscle weakness (P\u2009=\u20090.02 and P\u2009=\u20090.006, respectively), lower creatinine kinase levels (P\u2009&amp;lt;\u20090.0001) and less dyspnoea (P\u2009=\u20090.003).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Anti-SAE positive DM is a rare subgroup associated with typical skin features but a potentially diffuse rash, a mild myopathy. Interstitial lung disease defines an organizing pneumonia pattern. Cancer associated DM prevalence is five times that of the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, http:\/\/clinicaltrials.gov, NCT04637672.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead154","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T21:28:46Z","timestamp":1680211726000},"page":"3932-3939","source":"Crossref","is-referenced-by-count":30,"title":["Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5728-3019","authenticated-orcid":false,"given":"Juliette","family":"Demortier","sequence":"first","affiliation":[{"name":"Department of Dermatology, Henri Mondor University Hospital, AP-HP , Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Vautier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Sorbonne Universit\u00e9, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8400-4310","authenticated-orcid":false,"given":"Olivier","family":"Chosidow","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Henri Mondor University Hospital, Universit\u00e9 Paris-Est Cr\u00e9teil, AP-HP , Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7020-1954","authenticated-orcid":false,"given":"Laure","family":"Gallay","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Edouard Herriot University Hospital, Claude Bernard University Lyon1 , Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3815-5417","authenticated-orcid":false,"given":"Didier","family":"Bessis","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Center of Montpellier , Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Berezne","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHR Annecy-Genevois , Annecy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1679-8005","authenticated-orcid":false,"given":"Nad\u00e8ge","family":"Cordel","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Clinical Immunology, Guadeloupe University Hospital, Pointe-\u00e0-Pitre, Guadeloupe and Normandie University, UNIROUEN, IRIB, Inserm, U1234 , Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Amiens-Picardie Nord University Hospital , Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Smail","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Amiens-Picardie Nord University Hospital , Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Duffau","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Saint Andr\u00e9, Bordeaux University Hospital , Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Jachiet","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Saint-Louis Hospital, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Begon","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ren\u00e9 Dubos Hospital , Pontoise, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Gottlieb","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Bic\u00eatre Hospital, Universit\u00e9 Paris-Sud, AP-HP , Le Kremlin-Bic\u00eatre Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Chasset","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tenon Hospital, Sorbonne Universit\u00e9, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Graveleau","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CH de St Nazaire , St Nazaire, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Marque","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Caremeau Hospital, N\u00eemes University Hospital , N\u00eemes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Cesbron","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Le Mans Hospital Center , Le Mans, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Forestier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Mutualiste , Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Josse","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Dieppe Hospital , Dieppe, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Kluger","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Helsinki University Hospital , Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Beauch\u00eane","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Angers University Hospital , Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Le Corre","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Angers University Hospital , Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Pagis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Beaujon Hospital, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Rigolet","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Sorbonne Universit\u00e9, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Guillaume-Jugnot","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Sorbonne Universit\u00e9, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0182-2052","authenticated-orcid":false,"given":"Fran\u00e7ois-J\u00e9r\u00f4me","family":"Authier","sequence":"additional","affiliation":[{"name":"Department of Pathology, Henri-Mondor University Hospital, Institut Mondor de Recherche Biom\u00e9dicale, INSERM, Centre de Reference pour les Maladies Neuromusculaires of Nord-Est-\u00cele de France, Universit\u00e9 Paris-Est Cr\u00e9teil, AP-HP , Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Guilain","sequence":"additional","affiliation":[{"name":"Department of Pathology, Amiens Picardie University Hospital , Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Streichenberger","sequence":"additional","affiliation":[{"name":"Neuropathology Department, Hospices Civils Lyon, Claude Bernard University Lyon1 , Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Leonard-Louis","sequence":"additional","affiliation":[{"name":"Neuropathology Department, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Sorbonne Universit\u00e9, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Boussouar","sequence":"additional","affiliation":[{"name":"ICT Cardiothoracic Imaging Unit, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, AP-HP, Sorbonne Universit\u00e9 , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oc\u00e9ane","family":"Landon-Cardinal","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), CHUM Research Center, Department of Medicine, Universit\u00e9 de Montr\u00e9al , Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Sorbonne Universit\u00e9, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Allenbach","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Sorbonne Universit\u00e9, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"2023120200575626800_kead154-B1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2013.11.005","article-title":"The clinical features, diagnosis and classification of dermatomyositis","volume":"48\u201349","author":"Iaccarino","year":"2014","journal-title":"J Autoimmun"},{"key":"2023120200575626800_kead154-B2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","article-title":"Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study","volume":"77","author":"Dobloug","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2023120200575626800_kead154-B3","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"2023120200575626800_kead154-B4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","article-title":"Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients","volume":"101","author":"Betteridge","year":"2019","journal-title":"J Autoimmun"},{"key":"2023120200575626800_kead154-B5","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1002\/art.22862","article-title":"Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis","volume":"56","author":"Betteridge","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2023120200575626800_kead154-B6","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/ard.2008.097162","article-title":"Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis","volume":"68","author":"Betteridge","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2023120200575626800_kead154-B7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/annrheumdis-2012-201736","article-title":"Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort","volume":"72","author":"Fujimoto","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"2023120200575626800_kead154-B8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41598-017-00240-6","article-title":"Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts","volume":"7","author":"Ge","year":"2017","journal-title":"Sci Rep"},{"key":"2023120200575626800_kead154-B9","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.011","article-title":"Four dermatomyositis-specific autoantibodies\u2014anti-TIF1\u03b3, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort","volume":"13","author":"Bodoki","year":"2014","journal-title":"Autoimmun Rev."},{"key":"2023120200575626800_kead154-B10","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s10067-019-04562-w","article-title":"Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody\u2013associated dermatomyositis: a case report and literature review","volume":"38","author":"Jia","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2023120200575626800_kead154-B11","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/1756-185X.13593","article-title":"Two cases with autoantibodies to small ubiquitin-like modifier activating enzyme: a potential unique subset of dermatomyositis-associated interstitial lung disease","volume":"22","author":"Gono","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2023120200575626800_kead154-B12","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/rheumatology\/kev247","article-title":"High incidence of cancer in anti-small ubiquitin-like modifier activating enzyme antibody\u2013positive dermatomyositis","volume":"54","author":"Muro","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2023120200575626800_kead154-B13","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1097\/RHU.0000000000000683","article-title":"Anti-SAE antibody\u2013positive dermatomyositis in a Japanese patient: a case report and review of the literature","volume":"25","author":"Matsuo","year":"2019","journal-title":"J Clin Rheumatol"},{"key":"2023120200575626800_kead154-B14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/08916934.2012.755958","article-title":"Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients","volume":"46","author":"Muro","year":"2013","journal-title":"Autoimmunity"},{"key":"2023120200575626800_kead154-B15","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1093\/rheumatology\/keaa034","article-title":"Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis","volume":"59","author":"Zuo","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2023120200575626800_kead154-B16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/acr2.11247","article-title":"A North American cohort of anti-SAE dermatomyositis: clinical phenotype, testing, and review of cases","volume":"3","author":"Albayda","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"2023120200575626800_kead154-B17","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/bjd.17026","article-title":"Diffuse erythema with \u2018angel wings\u2019 sign in Japanese patients with anti-small ubiquitin-like modifier activating enzyme antibody\u2013associated dermatomyositis","volume":"179","author":"Inoue","year":"2018","journal-title":"Br J Dermatol"},{"key":"2023120200575626800_kead154-B18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","article-title":"239th ENMC International Workshop: classification of dermatomyositis, Amsterdam, The Netherlands, 14\u201316 December 2018","volume":"30","author":"Mammen","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"2023120200575626800_kead154-B19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jim.2012.07.019","article-title":"Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort","volume":"384","author":"Tarricone","year":"2012","journal-title":"J Immunol Methods"},{"key":"2023120200575626800_kead154-B20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"2023120200575626800_kead154-B21","first-page":"277","article-title":"This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS Board of Directors, June 2001 and by the ERS Executive Committee, June 2001","volume":"165","author":"American Thoracic Society, European Respiratory Society. American Thoracic Society\/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2023120200575626800_kead154-B22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"2023120200575626800_kead154-B23","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/jdv.14759","article-title":"Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients","volume":"32","author":"Best","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023120200575626800_kead154-B24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/practneurol-2017-001860","article-title":"A tough one to swallow","volume":"18","author":"Mulroy","year":"2018","journal-title":"Pract Neurol"},{"key":"2023120200575626800_kead154-B25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12026-018-9006-7","article-title":"Antibodies to small ubiquitin-like modifier activating enzyme are associated with a diagnosis of dermatomyositis: results from an unselected cohort","volume":"66","author":"Peterson","year":"2018","journal-title":"Immunol Res"},{"key":"2023120200575626800_kead154-B26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.revmed.2018.11.003","article-title":"[Retrospective analysis of anti-TIF1gamma, anti-NXP2 and anti-SAE1\/2 antibodies carriers at Bordeaux University Hospital from November 2014 to February 2017]","volume":"40","author":"Victor","year":"2019","journal-title":"Rev Med Interne"},{"key":"2023120200575626800_kead154-B27","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/rheumatology\/kez031","article-title":"Gastrointestinal manifestation of anti-SAE dermatomyositis","volume":"58","author":"Wells","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2023120200575626800_kead154-B28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10067-018-4267-z","article-title":"Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies","volume":"38","author":"Zampeli","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2023120200575626800_kead154-B29","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/bjd.15020","article-title":"Cutaneous features of dermatomyositis associated with myositis-specific antibodies","volume":"176","author":"Daly","year":"2017","journal-title":"Br J Dermatol"},{"key":"2023120200575626800_kead154-B30","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1111\/ajd.12659","article-title":"Recalcitrant ulcers associated with anti-small ubiquitin-like modifier activating enzyme\u2013positive dermatomyositis treated with surgery followed by intravenous immunoglobulin","volume":"59","author":"Lee","year":"2018","journal-title":"Australas J Dermatol"},{"key":"2023120200575626800_kead154-B31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12969-021-00532-2","article-title":"Anti-SAE autoantibody\u2013positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease \u2013 a case report","volume":"19","author":"Kishi","year":"2021","journal-title":"Pediatr Rheumatol"},{"key":"2023120200575626800_kead154-B32","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa2117912","article-title":"Trial of intravenous immune globulin in dermatomyositis","volume":"387","author":"Aggarwal","year":"2022","journal-title":"N Engl J Med"},{"key":"2023120200575626800_kead154-B33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/bjoc.2001.1699","article-title":"Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study","volume":"85","author":"Stockton","year":"2001","journal-title":"Br J Cancer"},{"key":"2023120200575626800_kead154-B34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead154\/50096843\/kead154.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/12\/3932\/53972294\/kead154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/12\/3932\/53972294\/kead154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T19:58:10Z","timestamp":1701460690000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/12\/3932\/7100338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,4,3]]},"published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead154","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12,1]]},"published":{"date-parts":[[2023,4,3]]}}}